Impact of sertraline on weight, waist circumference and glycemic control: A prospective clinical trial on depressive diabetic type 2 patients
• Sertraline improved anthropometrics variables in depressed type 2 diabetic patients. • At week 12, sertraline 50mg produced 2.5% loss in body weight from baseline. • Depressive patients under sertraline lost on average seven centimeters in waist circumference. • Sertraline was effective and safe i...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
|
|---|
| 1. Verfasser: |
Rachdi, Chaima
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Damak, Rahma
(BerichterstatterIn),
Fekih Romdhane, Feten
(BerichterstatterIn),
Ouertani, Haroun
(BerichterstatterIn),
Cheour, Majda
(BerichterstatterIn) |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2019
|
|---|
| Zugriff auf das übergeordnete Werk: | A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|
|---|
| Schlagworte: | Glycemic control
Body mass index
Depression
Type 2 diabetes mellitus
Sertraline |
|---|
| Umfang: | 6 |
|---|